Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Increases By 234.8%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 7,700 shares, an increase of 234.8% from the February 28th total of 2,300 shares. Based on an average daily volume of 38,800 shares, the days-to-cover ratio is presently 0.2 days.

Reviva Pharmaceuticals Price Performance

Shares of RVPHW traded down $0.00 during mid-day trading on Friday, hitting $0.05. The company’s stock had a trading volume of 6,003 shares, compared to its average volume of 25,095. The company’s 50-day moving average is $0.13 and its 200-day moving average is $0.16. Reviva Pharmaceuticals has a 52-week low of $0.04 and a 52-week high of $0.78.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.